Results 231 to 240 of about 696,455 (247)

The Pathogenesis of Rheumatoid Arthritis

New England Journal of Medicine, 2011
Georg Schett, Iain McInnes
exaly  

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

New England Journal of Medicine, 2000
Michael H Weisman, Josef S Smolen, Paul Emery   +2 more
exaly  

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

New England Journal of Medicine, 2012
Ronald van Vollenhoven, Gene Wallenstein, Roy Fleischmann   +2 more
exaly  

Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig

New England Journal of Medicine, 2003
Joel M Kremer, Rieke Alten, Paul Emery
exaly  

Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications

New England Journal of Medicine, 1996
James R O'Dell, James R O’Dell
exaly  

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

New England Journal of Medicine, 2020
Maureen Rischmueller, Ricardo Machado Xavier, Andrea Rubbert-Roth   +2 more
exaly  

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

New England Journal of Medicine, 2004
Paul Emery, Jonathan Edwards, Randall M Stevens   +2 more
exaly  

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

New England Journal of Medicine, 1997
Roy Fleischmann, Larry Moreland, Michael H Schiff   +2 more
exaly  

Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis

New England Journal of Medicine, 1978
P Stastny
exaly  

Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

New England Journal of Medicine, 2001
Ernest Choy, Gabriel S Panayi
exaly